ロード中...
Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add‐on therapy compared to levetiracetam and valproic acid
AIMS: Irritability has been described as a frequent adverse event in patients affected by epilepsy and treated with perampanel (PER), levetiracetam (LEV), and less frequently with valproic acid (VPA). Since the questionnaire for irritability (I‐EPI) is a validated instrument to measure this psychiat...
保存先:
| 出版年: | CNS Neurosci Ther |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6488879/ https://ncbi.nlm.nih.gov/pubmed/30675751 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.13098 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|